FDA approves new indication for YAZ[R] to treat emotional and physical symptoms of premenstrual dysphoric disorder
Women who have a history of depression are more likely to experience depressive symptoms or be given a diagnosis of MDD, particularly if the earlier episode of depression was associated with a reproductive event, such as postnatal blues, postpartum depression, or premenstrual dysphoric disorder
Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder
For the treatment of premenstrual dysphoric disorder
, a double-blind trial found that a dosage of 2 g three times per day during the second half of the menstrual cycle was beneficial.
Fluoxetine versus Vitex agnuscastus extract in the treatment of premenstrual dysphoric disorder
What sets Yaz apart is the fact that it is the first and only oral contraceptive that has been approved to treat the emotional as well as physical symptoms of premenstrual dysphoric disorder
(PMDD), which can include irritability, fatigue, moodiness, anxiety and bloating.
If you are particularly unfortunate, you may have a more severe form of PMS known as premenstrual dysphoric disorder
(PMDD), in which the emotional symptoms, such as depression, mood swings, anxiety and tension, are particularly serious.
FDA approves new indication for YAZ to treat emotional and physical symptoms of premenstrual dysphoric disorder
Premenstrual dysphoric disorder
(PMDD): The syndrome of more severe depression, irritability and tension occurring seven to 14 days prior to the start of the menstrual period is known as premenstrual dysphoric disorder
(PMDD) (also called late-luteal phase dysphoric disorder).
Bearing that in mind, consider that the current manual contains some 370 mental disorders, including such things as Sibling Rivalry Disorder, Mathematics Disorder, Caffeine Related Disorder and Premenstrual Dysphoric Disorder
-- the latest term for PMS.
revised; American Psychiatric Association, 1994) under the diagnostic category of Premenstrual Dysphoric Disorder
Women who take oral contraceptives are less likely to develop multiple sclerosis and premenstrual dysphoric disorder